We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Cost effectiveness of peginterferon alpha-2a plus ribavirin versus interferon alpha-2b plus ribavirin as initial therapy for treatment-naive chronic hepatitis C.
- Authors
Sullivan, Sean D; Craxi, Antonio; Alberti, Alfredo; Giuliani, Giovanni; De Carli, Claudio; Wintfeld, Neil; Patel, Kavita K; Green, Jesse
- Abstract
In adults with previously untreated chronic hepatitis C (CHC), the combination of peginterferon alpha-2a plus ribavirin produces a higher rate of sustained virological response (SVR) than interferon alpha-2b plus ribavirin, but it is still unproven whether this increase is cost effective. The objective of this study was to determine if the gain in SVR with peginterferon alpha-2a plus ribavirin is worth the incremental cost.
- Publication
PharmacoEconomics, 2004, Vol 22, Issue 4, p257
- ISSN
1170-7690
- Publication type
Journal Article
- DOI
10.2165/00019053-200422040-00004